Capital World Investors Zai Lab LTD Transaction History

Capital World Investors

$592 Billion
Q1 2025

A detailed history of Capital World Investors transactions in Zai Lab LTD stock. As of the latest transaction made, Capital World Investors holds 6,008,419 shares of ZLAB stock, worth $216 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

6,008,419

Previous 6,433,424 6.61%

Holding current value

$216 Million

Previous $168 Million 28.88%

% of portfolio

0.04%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$24.29 - $38.35 $10.3 Million - $16.3 Million	-425,005 Reduced 6.61%	6,008,419 $217 Million
Q4 2024 Feb 13, 2025	SELL	$24.61 - $33.18 $48,210 - $64,999	-1,959 Reduced 0.03%	6,433,424 $168 Million
Q3 2024 Nov 13, 2024	BUY	$16.25 - $24.14 $18.3 Million - $27.2 Million	1,127,444 Added 21.24%	6,435,383 $155 Million
Q2 2024 Aug 13, 2024	SELL	$13.72 - $21.55 $5.16 Million - $8.11 Million	-376,241 Reduced 6.62%	5,307,939 $92 Million
Q1 2024 May 14, 2024	BUY	$15.95 - $26.8 $7.42 Million - $12.5 Million	465,337 Added 8.92%	5,684,180 $91.1 Million
Q3 2023 Nov 13, 2023	SELL	$22.72 - $31.49 $107,352 - $148,790	-4,725 Reduced 0.09%	5,218,843 $127 Million
Q2 2023 Aug 11, 2023	BUY	$25.3 - $39.67 $14.1 Million - $22.1 Million	557,699 Added 11.95%	5,223,568 $145 Million
Q1 2023 May 15, 2023	BUY	$30.21 - $48.1 $124 Million - $197 Million	4,095,725 Added 718.37%	4,665,869 $155 Million
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $359,031 - $542,641	-10,498 Reduced 1.81%	570,144 $19.5 Million
Q2 2022 Aug 15, 2022	SELL	$23.14 - $49.68 $29.3 Million - $63 Million	-1,268,216 Reduced 68.59%	580,642 $20.1 Million
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $62.1 Million - $144 Million	-2,235,387 Reduced 54.73%	1,848,858 $81.3 Million
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $141 Million - $270 Million	-2,562,492 Reduced 38.55%	4,084,245 $257 Million
Q3 2021 Nov 15, 2021	SELL	$105.0 - $178.37 $246 Million - $418 Million	-2,344,731 Reduced 26.08%	6,646,737 $701 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $76.7 Million - $110 Million	612,742 Added 7.31%	8,991,468 $1.59 Billion
Q1 2021 May 14, 2021	SELL	$126.27 - $191.71 $21.8 Million - $33.1 Million	-172,716 Reduced 2.02%	8,378,726 $1.12 Billion
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $132 Million - $217 Million	1,604,838 Added 23.1%	8,551,442 $1.16 Billion
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $75 Million - $91.6 Million	1,023,276 Added 17.28%	6,946,604 $578 Million
Q2 2020 Aug 14, 2020	BUY	$48.82 - $82.53 $2.22 Million - $3.76 Million	45,569 Added 0.78%	5,923,328 $486 Million
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $230 Million - $370 Million	5,877,759 New	5,877,759 $303 Million

Others Institutions Holding ZLAB

# of Institutions

174

Shares Held

52.2M

Call Options Held

92.9K

Put Options Held

318K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.53B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account

Capital World Investors Zai Lab LTD Transaction History